Editorial: Advancements in P2X7 antagonists: from mechanistic insights to therapeutic applications
The purinergic receptor P2X7, cloned in the 1990s, is distinctive in that, beyond the initial 14 opening of a cationic channel at lower ATP concentrations, s...
1. Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
2. Laboratory of Technological Development in Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
3. Federal Institute of Education, Science and Technology of Rio de Janeiro, Rio de Janeiro, Brazil